Brief: GenOway FY EBITDA Up At 3.2 Million Euros

genOway SA

06/04/2023 17:13

April 6 (Reuters) - Genoway SA  ALGEN.PA :
    * RECORD 2022 RESULTS: ORGANIC REVENUE GROWTH OF +22%,
SUSTAINED
EBITDA GROWTH OF +119% AND NOW POSITIVE OPERATING CASH FLOW
    * FY EBITDA OF EUR 3.2 MILLION, UP +119%, DRIVEN BY GROWTH
OF THE
OVER 40% FOR THE 2ND CONSECUTIVE YEAR
    * FY REVENUE EUR 17.1 MILLION VERSUS EUR 14.0 MILLION YEAR
AGO
    * THE OPERATING RESULT IS NOW POSITIVE AT MEUR 1.0, UP BY
+1.4
MEUR COMPARED TO 2021
    * OUTLOOK: FISCAL YEAR 2023 IS EXPECTED TO BE A YEAR OF
SUSTAINED
GROWTH, SIMILAR TO 2022
    * OUTLOOK:  SEES A STRONG ACCELERATION OF ITS SALES, WHICH
WILL
FULLY CONTRIBUTE TO THE ACHIEVEMENT OF THE THE 30 MEUR SALES
TARGET SET AT THE BEGINNING OF THE STRATEGIC PLAN
    * THE COMPANY WILL UNVEIL A NEW 5-YEAR STRATEGIC PLAN IN THE
SECOND HALF OF 2023 STRATEGIC PLAN FOR THE NEXT 5 YEARS
    * THE NET RESULT IS POSITIVE, TO STAND AT 0.8 MEUR IN 2022
AGAINST
-0.3 MEUR IN 2021

Source text for Eikon:  ID:nACT79250 
Further company coverage:  ALGEN.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))